PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33717416-5	2021	RA treatment increased osteoblast differentiation, cell viability and mineralization in MC3T3-E1 osteoblastic cells on Ti surface during differentiation, upregulating Runx-2 and OPG, but downregulating RANKL.	rosmarinic acid	0-2	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)	Mus musculus	178-181	
33717416-6	2021	This study suggest that RA should be applied as an effective functional and therapeutic substance to enhance osseointegration of osteoblast cells by increasing differentiation, mineralization, and bone formation through the RANKL/RANK/OPG pathway during the differentiation in MC3T3-E1 osteoblastic cells on the Ti surface.	rosmarinic acid	24-26	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)	Mus musculus	235-238